The Future of Surgical Robotics: Exploring Advanced Supply Chains and Manufacturing at 2026 Medtec

SHANGHAI, May 12, 2026 /PRNewswire/ -- In 2026, the surgical robotics industry continues to grow steadily. Recent reports show that both procedure volumes and system deployments are rising consistently. Intuitive Surgical surpassed expectations in its Q1 earnings, installing 431 da Vinci systems globally and generating $2.77 billion in revenue, a 23% increase year-on-year^[1],[2]. This reflects a broader trend: the global medical robotics companies and the surgical robotics sector are entering a phase of large-scale, high-speed development.

At the same time, the rapid expansion of the global medical robotics market is driving concurrent growth in complete systems, software, and upstream supply chains.

Global Surgical Robotics Market Outlook 2026

Conclusions from multiple authoritative research institutions point to the same trend: the global surgical robotics market continues to maintain double-digit growth.

• MarketsandMarkets estimates that the global surgical robotics market was approximately $11.98 billion in 2024, and will reach $27.14 billion by 2030, with a CAGR of 14.7% between 2025 and 2030^[3].
• Grand View Research estimates the global surgical robot systems market at USD 11,477.3 million in 2024, growing to USD 23,132.5 million by 2030, corresponding to a 12.4% CAGR^[4].
• The Business Research Company provides a more optimistic scenario, projecting the market at $11.15 billion in 2025 and $29.23 billion by 2030, with a CAGR of approximately 21.3%^[5].

Several key points can be summarized:

1. The market size for 2024–2025 is roughly in the $11–12 billion range, depending on statistical methodology.
2. By 2030, forecasts range from $23 to $29 billion, reflecting different assumptions regarding penetration rates across countries.
3. North America remains the largest regional market, while the Asia-Pacific region (especially China, Japan, South Korea, and India) is considered the fastest-growing. Expansion in these markets directly drives the global layout of surgical robot companies.
4. Current high-growth applications are concentrated in general surgery, gynecology and urology, orthopedic and spinal surgery, and thoracic & respiratory interventions.

Upstream Supply Chain: Core Components and Software

As more surgical robot manufacturers expand system deployments, the related upstream market is also rapidly growing, including precision transmissions, micro-sensors, endoscope modules, AI chips, and specialized consumables.

According to Grand View Research, the global surgical robot accessories market was $4.76 billion in 2023 and is projected to grow at a 14.0% CAGR from 2024 to 2030^[6]. Updated data from Towards Healthcare predicts that the global surgical robot accessories market will grow from $5.85 billion in 2024 to $13.63 billion by 2034, with a CAGR of 9.07%^[7].

2026 Medtec, known as Asia's Leading Medical Device Supply Chain Expo, is scheduled from 1st-3rd September. It serves as an important platform for interaction between surgical robot companies and supply chain enterprises, facilitating exploration of components, processes, and new materials.

The show will happen at Shanghai New International Expo Center from N1-N4 to provide solutions for medical device companies from R&D to Commercial Manufacturing. [Apply Now for Your Free 2026 Medtec Ticket]

Top 10 Surgical Robot Companies Global

The following is a list of 10 surgical robot companies worth noting:

Company	Segment	Key Data 2026	Innovative Products
Intuitive Surgical(US)	Laparoscopic	Q1 revenue $2.77B (+23%); 60% global share	da Vinci 5, Ion system
Medtronic(Ireland)	Soft-tissue	Hugo launched commercially in the US	Hugo robotic system
Johnson & Johnson (US)	Laparoscopic	Ottava filed for FDA approval	Ottava surgical system
Stryker (US)	Orthopedic	Mako platform leads joint replacement	Mako robotic system
Smith+Nephew (UK)	Orthopedic	AI planning for arthroplasty	CORIOGRAPH modeling service
CMR Surgical (UK)	Laparoscopic	Modular portable design	Versius robotic system
MicroPort MedBot (China)	Laparoscopic	200+ global orders for Toumai	Toumai laparoscopic robot
Jingfeng Medical (China)	Laparoscopic	184.83% revenue growth in 2025	Multi-port + single-port integrated platform
Tinavi (China)	Orthopedic	>40% China market share	Tianji AIO orthopedic robot
Cornerstone Robotics (China)	Laparoscopic	Full-stack independent R&D	Sentire laparoscopic robot

Company

Segment

Key Data 2026

Innovative Products

Intuitive Surgical(US)

Laparoscopic

Q1 revenue $2.77B (+23%); 60% global share

da Vinci 5, Ion system

Medtronic(Ireland)

Soft-tissue

Hugo launched commercially in the US

Hugo robotic system

Johnson &
Johnson (US)

Laparoscopic

Ottava filed for FDA approval

Ottava surgical system

Stryker (US)

Orthopedic

Mako platform leads joint replacement

Mako robotic system

Smith+Nephew (UK)

Orthopedic

AI planning for arthroplasty

CORIOGRAPH modeling service

CMR Surgical (UK)

Laparoscopic

Modular portable design

Versius robotic system

MicroPort MedBot (China)

Laparoscopic

200+ global orders for Toumai

Toumai laparoscopic robot

Jingfeng Medical (China)

Laparoscopic

184.83% revenue growth in 2025

Multi-port + single-port integrated platform

Tinavi (China)

Orthopedic

>40% China market share

Tianji AIO orthopedic robot

Cornerstone Robotics (China)

Laparoscopic

Full-stack independent R&D

Sentire laparoscopic robot

Table: Quick Overview of Leading Surgical Robot Companies, 2026. Data sources: consolidated from industry reports, market research, and publicly available company information.

Global Competitive Landscape of Surgical Robotics Companies

North America remains the largest and most mature market for surgical robots, accounting for approximately 60–65% of the global market^[3].
Intuitive Surgical maintains a significant installed base in soft-tissue robotics, particularly with increasing penetration in general surgery areas such as gallbladder, appendix, and colorectal procedures. In orthopedics, Stryker, Zimmer Biomet, and Smith+Nephew compete intensely in knee and hip replacement robotics, offering hospitals multiple options.

China has become one of the fastest-growing key regional markets for surgical robots worldwide.
According to Frost & Sullivan, the total Chinese surgical robotics market is expected to reach RMB 22.45 billion in 2026, and RMB 70.85 billion by 2030, representing a CAGR of 33.3%^[8,9]. In 2025, domestic laparoscopic surgical robots surpassed imported systems in quantity for the first time in public tenders.
Notable Chinese surgical robot companies include MicroPort MedBot (Toumai), Jingfeng Medical (MP1000, CP1000), Tinavi (Tianji orthopedic robot), and Cornerstone Robotics (Sentire).

Other Countries and Regions

In Europe, Germany, the UK, France, and Italy are the most active adopters of surgical robots. Market research generally identifies these countries as the main sources of market growth in Europe. 

Overall, the global surgical robotics market is forming a multi-layered competitive landscape: on one level, global surgical robot companies compete internationally; on another, international and local brands contest emerging markets such as Asia; additionally, there is intense competition across different price ranges and clinical specialties. This competitive landscape is likely to continue evolving over the next few years.

Exploring Innovation at 2026 Medtec

In 2026, numerous leading surgical robot companies and their engineering teams will gather on-site at Medtec to identify reliable component partners, new materials, and process innovations. For professional attendees seeking insight into global and Asia-based supply chains, Medtec provides an ideal setting to observe interactions between surgical robot companies and the upstream ecosystem.

Typical categories of surgical robotics supply chain exhibitors at Medtec include medical materials, robotic arm contract manufacturing, endoscope modules, optical lenses, specialty cables, motors, and sterilized consumables.

Schedule your visit to discover opportunities for supply chain partnerships.

References:

1. Earnings call transcript: Intuitive Surgical Q1 2026 beats forecasts, stock reacts. Available at: https://www.investing.com/news/transcripts/earnings-call-transcript-intuitive-surgical-q1-2026-beats-forecasts-stock-reacts-93CH-4627814
2. Intuitive Announces First Quarter Earnings. Available at: https://finance.yahoo.com/sectors/healthcare/articles/intuitive-announces-first-quarter-earnings-203800175.html?guccounter=1
3. Surgical Robots Market Size, Growth, Share & Trends Analysis. Available at: https://www.marketsandmarkets.com/Market-Reports/surgical-robots-market-256618532.html
4. Global Surgical Robot Systems Market Size & Outlook. Available at： https://www.grandviewresearch.com/horizon/outlook/surgical-robot-systems-market-size/global
5. Surgical Robots Market Report 2026. Available at: https://www.thebusinessresearchcompany.com/report/surgical-robots-global-market-report
6. Surgical Robot Accessories Market (2024 - 2030). Available at: https://www.grandviewresearch.com/industry-analysis/surgical-robot-accessories-market-report
7. Surgical Robot Accessories Market Evolution with AI Integration. Available at: https://www.towardshealthcare.com/insights/surgical-robot-accessories-market-sizing
8. Available at:  https://www.toutiao.com/article/7625686968088773158/
9. Available at:  https://pdf.dfcfw.com/pdf/H3_AP202503191644657327_1.pdf?1742383413000.pdf

 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

The Future of Surgical Robotics: Exploring Advanced Supply Chains and Manufacturing at 2026 Medtec

With the world's first Video Plan, powered by Vidu Q3, Vidu Claw creates complete ad campaigns from a single goal - no complex workflow, no per-tool pricing

SINGAPORE, May 12, 2026 /PRNewswire/ -- ShengShu Technology today unveils Vidu Claw, the first step toward building the AI CMO, starting from video. More than just a production tool, Vidu Claw acts as a genuine creative partner that integrates into marketing operations to plan campaigns and produce content. It delivers the strategic oversight of a world-class executive without the traditional constraints of human bandwidth, working hours, or production budgets.

To function as a true AI CMO, Vidu Claw combines two complementary skill sets. Vidu Skills drives the creative production layer, image generation, video synthesis, and cinematic consistency, powered by the proprietary Vidu Q3 model. Marketing Skills covers the strategic layer, integrating specialized capabilities such as trend analysis, scripting, and performance optimisation. Together, they form a complete pipeline that transforms a single brief into a ready-to-use advertisement, from first insight to final frame, with no manual handoffs.

The World's First Video Plan: Results, Not Credits

Despite rapid advances in generative AI, complete video production remains fragmented, expensive, and fundamentally opaque. Most "all-in-one" platforms are merely aggregators, routing tasks through third-party models and passing compounding costs to users as hidden credit charges that can quickly spiral into tens of thousands. This "aggregator tax" has shifted the barrier from production skill to unpredictable billing. Vidu Claw was built to shatter this ceiling, introducing the world's first Video Plan, a results-driven subscription that delivers finished ads. It charges complete advertising output rather than tool access or generation credits.

The result is a complete and high-quality advertisement, brands know exactly what they are paying for before they pay for it, and the bill, when it arrives, matches the price that was promised. Rather than absorbing the cost of every failed generation attempt and every revision cycle within a depleting credit balance, Video Plan users pay for results. It is a fundamental reframing of how advertising production is priced and a direct structural challenge to every other platform in the market.

One Brief. One Ad. Complete Video Production Without Complexity.

Built on the open-source OpenClaw framework and powered by Vidu Q3, Vidu Claw is available directly within the Vidu platform, giving users zero-setup access to full-workflow marketing automation. Starting with a simple prompt or marketing objective, users can generate planning, scripting, storyboarding, asset creation, and platform-ready video output within a single system.

That simplicity is made possible by the platform underneath it. Unlike aggregator tools that route requests through a patchwork of third-party models, Vidu Claw generates every frame of video natively through Vidu Q3. Operating directly on the Vidu platform also gives users access to the Vidu Skills system, a library of thousands of specialised AI video and marketing capabilities designed for professional advertising and content production. These purpose-built skills support a wide range of creative scenarios, from social video automation and script-to-video creation to AI avatars, text-to-video, and faceless video workflows. The system is also open and extensible, allowing teams to integrate Vidu Skills into existing workflows through OpenClaw, Claude Code, and other compatible agent environments.

The latest generation of Vidu Q3 represents a significant leap in both speed and accessibility. Available in two different modes, Flash Mode delivers 10-second 1080P clips in just 80 to 150 seconds, up to five times faster than industry speed benchmarks. The more complex Cinematic Mode produces a 10-second clip five minutes faster than the market average, and renders 720P videos in as little as one minute. By slashing wait times and reducing the cost of a one-hour production by up to $1,450, Vidu Q3 allows teams to focus on scaling creative output rather than managing render queues.

In practice, this means a user can move from idea to finished ad with almost no operational complexity. A brief as simple as "Create a short-form ad for a running shoe targeting young women on Instagram" is enough for Vidu Claw to generate the creative concept, script, storyboard, visuals, voiceover, music, and final video. Wherever a user can send a message, they can produce a professional advertisement.

This native platform advantage translates into a new set of production economics for AI video:

• On cost: Vidu Claw brings visual quality, cinematic language, and creative packaging previously reserved for large-budget campaigns within reach of brands of any size, reducing the total cost of a complete advertising video to approximately 1% of traditional production.
• On speed: The full production pipeline is compressed into a single automated workflow that can be completed in under a day. For high-demand assets such as social ads and e-commerce videos, what once required days of coordination becomes a same-day deliverable.
• On scale: By eliminating the credit passthrough costs that make volume uneconomical on aggregator platforms, Vidu Claw allows teams to produce and iterate at a previously prohibitive scale. Instead of investing in one hero asset and hoping it converts, marketers can generate, deploy, and A/B test multiple creative variations in the time it once took to produce one.

Full-Workflow Marketing Automation

Beyond mere production, Vidu Claw functions as a 24/7 AI CMO, it automates the entire marketing workflow, from strategic planning through to final content delivery. At its core is the Marketing Skills orchestration layer, integrating tens of thousands of specialised marketing capabilities across the full production pipeline, including trend analysis and insights, marketing script generation, storyboarding and shot design, asset generation (visuals, background music, video synthesis), social media creatives and copywriting, performance tracking and analytics, and document generation (PPT, DOC, reports).

This flexible intelligent orchestration layer dynamically selects the most suitable models and resources for each objective. Vidu Claw moves AI from a passive assistant to a core creative teammate, enabling brands to scale their marketing operations with unprecedented speed and data-driven precision.

A New Standard For Marketing Infrastructure

The launch of Vidu Claw marks a fundamental shift in how AI participates in real-world production. It does more than lower the barrier to content creation, but it redefines how marketing work gets done. By understanding goals, autonomously breaking down tasks, and executing them end to end, AI moves from a passive tool into an always-on creative teammate for brands and marketers of every size

Vidu Claw is available now at https://www.vidu.com/vidu-claw

To access the visual assets, click here

About ShengShu Technology

Founded in 2023, ShengShu Technology is the world's first general world model company dedicated to unifying the digital and physical worlds. Built around World Foundation Models (WFMs), the company has developed Vidu, a multimodal model for the digital world designed to generate temporally consistent content and enable interactive experiences, advancing the intelligent evolution of content creation. In the physical world, ShengShu Technology has launched Motubrain, a World Action Model that integrates perception, prediction, and action, accelerating the development of embodied intelligence toward general-purpose robotic agents.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

ShengShu Technology Unveils Vidu Claw, the AI CMO That Turns a Single Brief Into a Finished Ad